Thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies during the pregnancy and postpartum period: a case report.

This report describes a unique pattern of changes in thyroid function and thyroid antibodies in a woman during the course of two pregnancies and two postpartum periods. A 25-year-old woman developed hypothyroidism in the postpartum period after the delivery of her first child. She was found to have potent thyroid stimulation-blocking antibodies (TSBAb) in the serum. One year later, she became pregnant again, and during the pregnancy, TSBAb had decreased to an undetectable level. She gave birth to the second healthy child and developed postpartum thyrotoxicosis, probably due to destruction of the thyroid gland, which gradually resolved. In this postpartum period, serum TSBAb levels increased. Eight months postpartum, she developed what appeared to be Graves' disease with an elevated 123I-thyroid uptake. Serum thyroid-stimulating antibodies (TSAb) were found at that time, and the TSBAb had disappeared from her serum.

[1]  S. Fukata,et al.  Transient postpartum hypothyroidism caused by thyroid-stimulation-blocking antibody , 1990, The Lancet.

[2]  H. Hatabu,et al.  PRESENCE OF BOTH STIMULATING AND BLOCKING TYPES OF TSH‐RECEPTOR ANTIBODIES IN SERA FROM THREE PATIENTS WITH PRIMARY HYPOTHYROIDISM , 1990, Clinical endocrinology.

[3]  H. Kitaoka,et al.  DEVELOPMENT OF HYPERTHYROIDISM FOLLOWING PRIMARY HYPOTHYROIDISM: A CASE REPORT WITH CHANGES IN THYROID‐RELATED ANTIBODIES , 1988, Clinical endocrinology.

[4]  Y. Iwatani,et al.  IN‐VITRO CONVERSION OF BLOCKING TYPE ANTI‐TSH RECEPTOR ANTIBODY TO THE STIMULATING TYPE BY ANTI‐HUMAN IgG ANTIBODIES , 1987, Clinical endocrinology.

[5]  J. Konishi,et al.  A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. , 1986, The Journal of clinical endocrinology and metabolism.

[6]  J. Mckenzie,et al.  Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease. , 1985, The Journal of clinical investigation.

[7]  J. Konishi,et al.  Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients. , 1985, Annals of Internal Medicine.

[8]  J. J. Taylor,et al.  Blocking activity to action of thyroid stimulating hormone in serum from patients with primary hypothyroidism. , 1984, British medical journal.

[9]  B. Smith,et al.  A RECEPTOR ASSAY FOR THE MEASUREMENT OF TSH RECEPTOR ANTIBODIES IN UNEXTRACTED SERUM , 1984, Clinical endocrinology.

[10]  J. Mckenzie,et al.  Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. , 1983, The Journal of clinical endocrinology and metabolism.

[11]  P. Vitti,et al.  Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Mckenzie,et al.  Clinical significance of assay of thyroid-stimulating antibody in Graves' disease. , 1980, Annals of internal medicine.

[13]  P. Walfish,et al.  POST-PARTUM TRANSIENT THYROTOXICOSIS WITH PAINLESS THYROIDITIS , 1977, The Lancet.